-
If you are a current long-term stockholder of shares of AngioDynamics, Inc. (NASDAQ:ANGO), you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
Sept. 17, 2012 (Shareholders Foundation) -- Certain officers and directors of AngioDynamics, Inc. are currently under investigation concerning whether they breached their fiduciary duties by paying excessive compensation to certain top officials at AngioDynamics, Inc. (NASDAQ:ANGO).
The investigation by a law firm focuses on whether certain directors and officers of AngioDynamics, Inc. harmed the company by agreeing to pay certain of AngioDynamics senior officers and executives excessive compensation.
million for the 52 weeks period that ended on May 31, 2009 to $221.79 million for the 52 weeks period that ended on May 31, 2012. However its Net Income of $9.93 million for the 52 weeks period that ended on May 31, 2009 declined to a Net Loss of $5.09 million for the 52 weeks period that ended on May 31, 2012.
Shares of AngioDynamics, Inc. (NASDAQ:ANGO) grew from as low as $9.91 per share in March 2009 to as high as $16.92 per share in February 2011. However, NASDAQ: ANGO shares fell in August 2012 to as low as $10.44 per share.
The new CEO of AngioDynamics, Inc. (NASDAQ:ANGO) earned a total of over $3.5 million in the Fiscal year 2012, while the former CEO earned a total of over $1.2 million in the Fiscal year 2012.
On September 13, 2012, shares of AngioDynamics, Inc. (NASDAQ:ANGO) closed at $12.24 per share.
